PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-08-17 pm EDT
39.63 USD   -5.28%
05:00pPerrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Over Heartburn Drug Zantac
MT
04:24pPerrigo releases statement on recent market trading activity
PR
11:27aGSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Perrigo Secures FDA's Final Approval for Omeprazole Heartburn Treatment

05/26/2022 | 09:41am EDT


© MT Newswires 2022
All news about PERRIGO COMPANY PLC
05:00pPerrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Ov..
MT
04:24pPerrigo releases statement on recent market trading activity
PR
11:27aGSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
08/16Plaintiff in first Zantac lawsuit set for trial drops case
RE
08/09PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
08/09Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ende..
CI
08/09Perrigo Cuts Full-Year Profit View on Currency Headwinds After Mixed Second-Quarter Res..
MT
08/09PERRIGO : REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERAT..
PU
08/09TRANSCRIPT : Perrigo Company plc, Q2 2022 Earnings Call, Aug 09, 2022
CI
08/09Perrigo Company Reports Lower Q2 Earnings, Higher Sales; Revises Full Year Guidance
MT
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Financials (USD)
Sales 2022 4 527 M - -
Net income 2022 - - -
Net Debt 2022 3 689 M - -
P/E ratio 2022 -
Yield 2022 2,58%
Capitalization 5 630 M 5 630 M -
EV / Sales 2022 2,06x
EV / Sales 2023 1,88x
Nbr of Employees 9 900
Free-Float 99,6%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 41,84 $
Average target price 50,00 $
Spread / Average Target 19,5%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC7.56%5 630
JOHNSON & JOHNSON-2.05%440 572
ELI LILLY AND COMPANY12.34%294 849
PFIZER, INC.-15.56%279 832
ROCHE HOLDING AG-16.74%273 886
ABBVIE INC.5.28%252 042